Owens & Minor (NYSE:OMI) Issues FY25 Earnings Guidance

Owens & Minor (NYSE:OMI) updated its FY25 earnings guidance on Friday. The company provided EPS guidance of $1.60-1.85 for the period, compared to the consensus EPS estimate of $1.79. The company issued revenue guidance of $10.85-11.15, compared to the consensus revenue estimate of $10.97 billion. Owens & Minor also updated its FY 2025 guidance to 1.600-1.850 EPS.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. Robert W. Baird cut their target price on Owens & Minor from $14.00 to $10.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 25th. Citigroup dropped their price target on Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. UBS Group dropped their price target on Owens & Minor from $25.00 to $13.00 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Finally, Barclays dropped their price target on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 5th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $14.92.

Owens & Minor Stock Up 38.7 %

NYSE:OMI opened at $9.56 on Friday. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09. The company has a market cap of $736.78 million, a PE ratio of -14.70, a PEG ratio of 0.20 and a beta of 0.48. Owens & Minor has a 52-week low of $6.07 and a 52-week high of $28.35. The stock has a 50-day simple moving average of $11.51 and a 200 day simple moving average of $13.24.

Owens & Minor (NYSE:OMI) last posted its quarterly earnings data on Friday, February 28th. The company reported $0.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.53 by $0.02. The business had revenue of $2.70 billion during the quarter, compared to the consensus estimate of $2.68 billion. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. Owens & Minor’s quarterly revenue was up 1.5% on a year-over-year basis. During the same period last year, the company earned $0.69 earnings per share. On average, sell-side analysts expect that Owens & Minor will post 1.51 EPS for the current fiscal year.

Owens & Minor declared that its board has initiated a share buyback program on Friday, February 28th that permits the company to buyback $100.00 million in shares. This buyback authorization permits the company to repurchase up to 13.6% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s board believes its shares are undervalued.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.